These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7486636)

  • 61. [Continuous pluriparametric surveillance in neuroresuscitation. Practical examples].
    Texier JJ; Bechonnet G; Lajoix M; Bricq M; Bougault A; Feiss P; Dany A
    Minerva Anestesiol; 1985; 51(7-8):371-6. PubMed ID: 3831819
    [No Abstract]   [Full Text] [Related]  

  • 62. [Neurophysiological indices of the CNS plasticity in the course of treatment of craniocerebral trauma in adolescents].
    Iznak AF; Iznak EV; Zavadenko NN; Guzilova LS
    Fiziol Cheloveka; 2008; 34(6):23-9. PubMed ID: 19133534
    [No Abstract]   [Full Text] [Related]  

  • 63. Increased intracranial pressure in head trauma patients given fentanyl or sufentanil.
    Kofke WA; Tempelhoff R
    Anesthesiology; 1993 Mar; 78(3):620-1. PubMed ID: 8457073
    [No Abstract]   [Full Text] [Related]  

  • 64. Cerebral hemodynamic changes in severe head injury patients undergoing decompressive craniectomy.
    Daboussi A; Minville V; Leclerc-Foucras S; Geeraerts T; Esquerré JP; Payoux P; Fourcade O
    J Neurosurg Anesthesiol; 2009 Oct; 21(4):339-45. PubMed ID: 19955897
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure.
    Munar F; Ferrer AM; de Nadal M; Poca MA; Pedraza S; Sahuquillo J; Garnacho A
    J Neurotrauma; 2000 Jan; 17(1):41-51. PubMed ID: 10674757
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Avoiding secondary brain injury after severe head trauma: monitoring and management.
    Verweij BH; Muizelaar JP
    J Craniomaxillofac Trauma; 1996; 2(3):8-17. PubMed ID: 11951458
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Effects of intravenous nitroglycerin on blood pressure, intracranial pressure and total and regional cerebral blood flow in cases of subarachnoid hemorrhage with vasospasm].
    Artru F; Philippon B; Poussel JF; Montarry M; Deleuze R
    Agressologie; 1984 Jun; 25(7):819-21. PubMed ID: 6435467
    [No Abstract]   [Full Text] [Related]  

  • 68. [Regional vasoactive and metabolic therapy of patients with severe cranio-cerebral traumas].
    Lapshin VN; Shakh BN; Teplov VM; Smirnov DB
    Vestn Khir Im I I Grek; 2012; 171(3):53-6. PubMed ID: 22880433
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The relationship of intracranial pressure Lundberg waves to electroencephalograph fluctuations in patients with severe head trauma.
    Lescot T; Naccache L; Bonnet MP; Abdennour L; Coriat P; Puybasset L
    Acta Neurochir (Wien); 2005 Feb; 147(2):125-9; discussion 129. PubMed ID: 15570441
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of a new neuroprotective agent, gacyclidine, in a model of rat spinal cord injury.
    Feldblum S; Arnaud S; Simon M; Rabin O; D'Arbigny P
    J Neurotrauma; 2000 Nov; 17(11):1079-93. PubMed ID: 11101210
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Physiological monitoring of the head-injured patient.
    Levin AB; Braun SR; Grossman JE
    Clin Neurosurg; 1982; 29():240-87. PubMed ID: 7172551
    [No Abstract]   [Full Text] [Related]  

  • 72. Strategies for neuroprotection with glutamate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies.
    Bullock R
    Ann N Y Acad Sci; 1995 Sep; 765():272-8; discussion 298. PubMed ID: 7486613
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acute tolerance to high-dose barbiturate treatment in patients with severe head injuries.
    Sawada Y; Sugimoto H; Kobayashi H; Ohashi N; Yoshioka T; Sugimoto T
    Anesthesiology; 1982 Jan; 56(1):53-4. PubMed ID: 7053672
    [No Abstract]   [Full Text] [Related]  

  • 74. Neuroprotective agents in severe head injury.
    Fearnside M
    Clin Exp Pharmacol Physiol; 1996 Aug; 23(8):S54-5. PubMed ID: 8886518
    [No Abstract]   [Full Text] [Related]  

  • 75. Cerebrovascular reactivity.
    Cruz J
    J Neurosurg; 1996 Feb; 84(2):306-8. PubMed ID: 8592244
    [No Abstract]   [Full Text] [Related]  

  • 76. Disadvantages of prolonged neuromuscular blockade in patients with head injury.
    Fahy BG; Matjasko MJ
    J Neurosurg Anesthesiol; 1994 Apr; 6(2):136-8. PubMed ID: 8012174
    [No Abstract]   [Full Text] [Related]  

  • 77. The tolerability, pharmacokinetics and pharmacodynamics of increasing intravenous doses of 619C89, a novel compound for the acute treatment of stroke, in healthy volunteers.
    Mercer AJ; Lamb RJ; Hussein Z; Hobbiger S; Posner J
    Ann N Y Acad Sci; 1995 Sep; 765():324-6. PubMed ID: 7486632
    [No Abstract]   [Full Text] [Related]  

  • 78. Challenges in translating the efficacy of neuroprotective agents in experimental models into knowledge of clinical benefits in head injured patients.
    Teasdale GM; Maas A; Iannotti F; Ohman J; Unterberg A
    Acta Neurochir Suppl; 1999; 73():111-6. PubMed ID: 10494352
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neuromuscular blockade in head-injured patients with increased intracranial pressure: continuous versus intermittent use.
    Wilson JA; Branch CL
    J Neurosurg Anesthesiol; 1994 Apr; 6(2):139-41. PubMed ID: 8012175
    [No Abstract]   [Full Text] [Related]  

  • 80. Increased intracranial pressure after fentanyl administration in a child with closed head trauma.
    Tobias JD
    Pediatr Emerg Care; 1994 Apr; 10(2):89-90. PubMed ID: 8029118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.